Leadership and Administrative Core (LAC)

领导和行政核心 (LAC)

基本信息

批准号：
10729790
负责人：
Olivia Ifeoma Okereke
金额：
$ 24.16万
依托单位：
MASSACHUSETTS GENERAL HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-09-01 至 2028-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10729790
关键词：
Academy Achievement Advocate Aging Alzheimer&apos s Disease Alzheimer&apos s disease related dementia Behavior Therapy Behavioral Research Benchmarking Biomedical Research Boston Caring Centers for Disease Control and Prevention (U.S.)Collaborations Communities Community Participation Data Dementia Development Elderly Ensure Evaluation Funding General Hospitals Goals Hospitals Infrastructure Institution Intervention Intervention Studies Investigation Knowledge Lead Leadership Massachusetts Medicine Mentors Methodology Minority Minority Health Research Mission Modeling Monitor New England Patients Performance Persons Pilot Projects Prevention Process Reporting Research Research Personnel Research Project Grants Resources Risk Behaviors Science Scientist Supervision System Testing Training Training Support Training and Infrastructure United States National Institutes of Health Universities Work anti-racism behavior change behavioral health behavioral health intervention career career development community center community engaged research community engagement community setting digital education research empowerment equity, diversity, and inclusion experience functional improvement health disparity informal care member next generation novel programs recruit skills success

项目摘要

The goal of the Leadership and Administrative Core (LAC) is to provide the overall infrastructure and scientific and intellectual leadership of the translational, interdisciplinary, collaborative, and investigator development functions that are expected of an AD/ADRD RCMAR. The Scientific Theme of Mass-ENVISION (Massachusetts Center for Alzheimer and dEmeNtia behaVIoral reSearch In minOrity agiNg) is the training and sustained and tailored mentoring of underrepresented in medicine (UiM) scientists in developing, testing and implementing of scientifically rigorous behavioral health interventions for persons with ADRD (Alzheimer disease and related dementias) and their informal care partners in hospital and community settings. The rationale for selecting this scientific theme is the critical need for new ADRD behavioral interventions as well as the need to diversify biomedical research, consistent with the call for ADRD behavioral research under RFA-AG-23-025. All RCMAR Scientists will receive training in ADRD behavioral health and interventions research anchored to the newly revised (2022) NIH Stage Model, the Science of Behavior Change, the NIA Health Disparities Framework and the CDC (Centers for Disease Control) and NAM (National Academy of Medicine) prevention models. The LAC will conduct its work through 3 Specific Aims. Aim 1. Establish the leadership, infrastructure and community to support the Mass-ENVISION Scientific Theme. The LAC will: Provide administrative leadership, oversight and facilitation of scientific interactions and collaborations across all Cores and component institutions, as well as with other regional NIA Centers, including 2 Alzheimer’s Disease Research Centers (ADRCs); Ensure that principles and practices of diversity, equity, inclusion, accessibility and anti-racism are integrated throughout all Cores and RCMAR Scientists’ training experiences; Promote a community-centered focus to the work conducted by all Cores. Aim 2. Support rigorous training and career development for RCMAR Scientists in the Mass-ENVISION Scientific Theme. The LAC will: Coordinate with the Research Education Component and Data and Analysis Core teams to support training of RCMAR Scientists in knowledge and methodologically rigorous application of novel ADRD behavioral health and interventions. Aim 3. Evaluate success of the RCMAR and of RCMAR Scientists. The LAC will: Create systems, resources and processes for monitoring of mentoring success and progress of RCMAR Scientists and pilot studies; Monitor, record and report performance metrics of this RCMAR and support dissemination of successful systems, resources and processes to other RCMARs, ADRCs and the scientific community. The LAC team will consist of PI Dr. Okereke, Associate Director Dr. Budson, a Program Manager, and LAC members Drs. Blacker, Gomez-Isla, Hyman and Keuroghlian; it includes senior leadership members of both the Massachusetts ADRC and Boston University ADRC. The LAC features high levels of leadership, administrative experience, and complementary skills to oversee and facilitate effective and impactful interactions and collaborations across all Cores, partnering institutions, stakeholders, and programs, to support the achievement of all Aims of Mass-ENVISION.

领导和行政核心（LAC）的目标是提供整体基础设施和科学和转化、跨学科、协作和研究者发展职能的智力领导 Mass-ENVISION 的科学主题（麻省阿尔茨海默病和老年痴呆症中心）少数民族痴呆症行为研究）是对代表性不足的人进行培训以及持续和量身定制的指导医学（UiM）科学家开发、测试和实施科学严格的行为健康对 ADRD（阿尔茨海默病和相关痴呆症）患者及其在医院的非正式护理伙伴的干预措施选择这个科学主题的理由是对新 ADRD 行为的迫切需要。干预措施以及生物医学研究多样化的需要，与 ADRD 行为研究的呼吁相一致根据 RFA-AG-23-025，所有 RCMAR 科学家都将接受 ADRD 行为健康和干预研究方面的培训。以新修订的 (2022) NIH 阶段模型、行为改变科学、NIA 健康差异为基础框架以及 CDC（疾病控制中心）和 NAM（美国国家医学院）预防模型。 LAC 将通过 3 个具体目标开展工作： 1. 建立领导层、基础设施和社区，以实现这一目标。支持 Mass-ENVISION 科学主题 LAC 将：提供行政领导、监督和便利。所有核心和组成机构之间以及与其他区域 NIA 之间的科学互动和合作中心，包括 2 个阿尔茨海默病研究中心 (ADRC)，确保多样性原则和实践，公平、包容、可及性和反种族主义融入所有核心和 RCMAR 科学家的培训中目标 2. 支持严格的培训。 Mass-ENVISION 科学主题中 RCMAR 科学家的职业发展和职业发展 LAC 将：研究教育部分以及数据和分析核心团队支持 RCMAR 科学家的培训目标 3. 评估新型 ADRD 行为健康和干预措施的知识和方法上的严格应用。 RCMAR 和 RCMAR 科学家的成功将：创建用于监测的系统、资源和流程。指导 RCMAR 科学家和试点研究的成功和进展；监控、记录和报告绩效指标；并支持向其他 RCMAR、ADRC 和其他 RCMAR 传播成功的系统、资源和流程 LAC 团队将由 PI 博士 Okereke、副主任 Budson 博士、项目经理、 LAC 成员 Blacker、Gomez-Isla、Hyman 和 Keuroghlian 博士；马萨诸塞州 ADRC 和波士顿大学 ADRC 拥有高水平的领导力、管理经验、以及互补技能，以监督和促进所有核心之间有效且有影响力的互动与协作，与机构、利益相关者和项目合作，支持实现 Mass-ENVISION 的所有目标。